SYMBOL:

    Up to 100 tickers separated by a space .....Watch Pre-Market activities
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
CORMEDIX INC
(AMEX:CRMD Last Sale: 4.15 +0)
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
AMEX: (CRMD : $4.15)
$108,426 million Market Cap at Market Close, July 1, 2022
Biomedics SubIndustry up .00% / Health Industry up .00% Today

745 Rt. 202-206, Suite 303 Research Report Earnings Snapshot - Last 11/13/18
Bridgewater, NJ 08807 Fact Sheet
Phone: (908) 517-9500 Financial Statements
Peer Comparison
Annual Reports

Richard M. Cohen, Chmn.
Focus is prevention and treatment of cardiac and renal dysfunction, also known as cardiorenal disease. CorMedix most advanced product candidate: CRMD003 (Neutrolin®) is for the prevention of catheter related bloodstream infections and maintenance of catheter patency in tunneled, cuffed, central venous catheters used for vascular access in hemodialysis patients.
Historical Charts    Technical Analysis
No Historical Data available for CRMD

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common CRMD $4.15 $4.15 0 .0 $3.74 $4.16 173,244 $3.74 $4.16 26,126,859
Warrants CRMD/WS $.11 $ 0 $.0795 $.11 14,909 $.0151 $.285 0
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock $108,426,465

A
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex